Skip to main content
SpringerLink
Log in

TGF-β and estrogen regulate P27Kip1 and cyclin D1 in normal and neoplastic rat pituitary cells

  • Basic Research
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Pituitary hyperplasia and tumor growth are regulated by various hormones and growth factors. Estrogen (E2) stimulates pituitary cell proliferation and prolactin (PRL) production. Estrogen also regulates transforming growth factor-β (TGF-β) effects in the pituitary. TGF-β in turn regulates various cell cycle proteins including p15 and p27Kip1 (p27). To better understand the regulatory role of growth factors and hormones in the cell cycle we analyzed cyclin D1, cyclin E, and p27 expression in normal and neoplastic rat pituitary cells. An in vitro analysis using cultured normal pituitary cells and GH3 tumor cells and an in vivo analysis of estrogen-treated normal pituitary and implanted GH3 cells were performed. Semiquantitative RT-PCR was used to analyze mRNA expression for cyclin D1, cyclin E, and p27 in cultured pituitary cells and E2-treated pituitaries in vivo. Cyclin D1 and p27 were localized in the nuclei of normal pituitary cells by immunocytochemistry (ICC). Very weak or absent immunostaining for cyclin D1 and p27 was present in GH3 cells. Both normal pituitary and GH3 cells had strong nuclear staining for cyclin E. Normal pituitary had a 20-fold greater amount of cyclin D1 mRNA and a 3-fold greater amount of p27 mRNA compared to GH3 cells, whereas GH3 cells had slightly (1.5-fold) more cyclin E than normal pituitary cells. E2 treatment in vivo stimulated cell proliferation and decreased cyclin D1 mRNA levels in normal pituitary. GH3 tumor cells, implanted subcutaneously in the same animal, showed increased proliferation after E2 treatment, but there was no change in cyclin D1 mRNA in GH3 cells. Cyclin E and p27 mRNA levels did not change significantly in normal pituitary or in GH3 cells after E2 treatment in vivo. Treatment of normal pituitary cells with 10−9 M TGF-β1 for 3 d in vitro led to significant decreases in cyclin D1 and p27 mRNAs (p < 0.05), whereas cyclin E levels were unchanged. These results indicate that cyclin D1 and p27 mRNAs are present at significantly higher levels in normal pituitary compared to GH3 cells, and that both E2 and TGF-β1 can downregulate cyclin D1 mRNA levels in normal pituitary cells, suggesting that these factors regulate G1 to S phase transition in pituitary cells. The lower levels of specific cell cycle regulators in GH3 cells may explain the decreased regulatory control by E2 in GH3 tumor cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Furth J, Ueda G, Clifton KH. The pathophysiology of pituitaries and their tumors: methodological advances. Meth Cancer Res 10:210–277, 1973.

    Google Scholar 

  2. Wiklund J, Wertz N, Gorski J. A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology 109:1700–1707, 1981.

    Article  PubMed  CAS  Google Scholar 

  3. Lloyd RV. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland: an immunohistochemical study. Am J Pathol 113:198–206, 1983.

    PubMed  CAS  Google Scholar 

  4. Lloyd RV, Cano M, Landefeld TD. The effects of estrogens on tumor growth and on prolactin and growth hormone in mRNA expression in rat pituitary tissues. Am J Pathol 133:397–406, 1988.

    PubMed  CAS  Google Scholar 

  5. Ramsdell JS. Transforming growth factor alpha and beta are potent and effective inhibitors of GH4 pituitary cell proliferation. Endocrinology 128:1981–1990, 1991.

    PubMed  CAS  Google Scholar 

  6. Sarkar DK, Kim KH, Minarni S. Transforming growth factor beta 1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth. Mol Endocrinol 6:1825–1833, 1992.

    Article  PubMed  CAS  Google Scholar 

  7. Burns G, Sarkar DK. Transforming growth factor beta-like immunoreactivity in the pituitary gland of the rat: effect of estrogen. Endocrinology 133:1444–1449, 1993.

    Article  PubMed  CAS  Google Scholar 

  8. Qian X, Jin L, Lloyd PV. Expression and regulation of transforming growth factor β1 in cultured normal and neoplastic rat pituitary cells. Endocr Pathol 7:77–90, 1996.

    PubMed  CAS  Google Scholar 

  9. Harrwell LH, Kastan MB. Cell cycle control and cancer. Science 266:1821–1828, 1994.

    Article  Google Scholar 

  10. Alexandrow MG, Moses HL. Transforming growth factor β and cell cycle regulation. Cancer Res 55:1452–1457, 1995.

    PubMed  CAS  Google Scholar 

  11. Coats S, Flanagan WM, Nourse J, Roberts JM. Requirement of p27kip1 for restriction point control of the fibroblast cell cycle. Science 272:877–880, 1996.

    Article  PubMed  CAS  Google Scholar 

  12. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J. Cloning of p27kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78(1):56–66, 1994.

    Article  Google Scholar 

  13. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J. Growth inhibition by TGF β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185, 1990.

    Article  PubMed  CAS  Google Scholar 

  14. Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF β. Science (Washington DC) 260:536–539, 1993.

    Article  CAS  Google Scholar 

  15. Ravitz MJ, Yan S, Herr KD, Wenner CE. Transforming growth factor β-induced activation of cyclin E-CDK2 kinase and down-regulation of p27kip1 in C3H 10T1/2 mouse fibroblast. Cancer Res 55:1413–1416, 1995.

    PubMed  CAS  Google Scholar 

  16. Qian X, Jin L, Grande JP, Lloyd RV. Transforming growth factor β and p27 expression in pituitary cells. Endocrinology 137:3051–3060, 1996.

    Article  PubMed  CAS  Google Scholar 

  17. Sherr CJ. G1 phase progression: cycling on cue. Cell 79(4):551–555, 1994.

    Article  PubMed  CAS  Google Scholar 

  18. Coleman TR, Dunphy WG. CDC2 regulatory factors. Curr Opinions Cell Biology 6(6):877–882, 1994.

    Article  CAS  Google Scholar 

  19. Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573–582, 1994.

    Article  PubMed  CAS  Google Scholar 

  20. Resnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14(3):1669–1679, 1994.

    PubMed  CAS  Google Scholar 

  21. Kato J-Y, Matsuoka M, Polyak K, Massabue J, Sherr CJ. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27kip1) of cyclin-dependent kinase 4 activation. Cell 79(3):487–496, 1994.

    Article  PubMed  CAS  Google Scholar 

  22. Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GB, Roberts JM Interleukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372(6506):507–513, 1994.

    Article  Google Scholar 

  23. Polyak K, Kato JY, Solomon MT, Sherr CJ, Massague J, Roberts JM, Koff A. p27kip1, a cyclin-CDK inhibitor, links transforming growth factor β and contact inhibition to cell cycle arrest. Genes Dev 8:9–22, 1994.

    Article  PubMed  CAS  Google Scholar 

  24. Moses HL, Yang KY, Pietenpol JA. TGF β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245–247, 1990.

    Article  PubMed  CAS  Google Scholar 

  25. Sewing A, Burger C, Brusselbach S, Schalk C, Lucibello FC, Muler R. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by clic AMP. J Cell Science 104:545–555, 1993.

    PubMed  CAS  Google Scholar 

  26. Bates S, Peters G. Cyclin D1 as a cellular proto-oncogene. Sem Cancer Biol 6:73–82, 1995.

    Article  CAS  Google Scholar 

  27. Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Intante AS, Doi S, Santella RM, Weinstein IB. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8:3447–3457, 1993.

    PubMed  CAS  Google Scholar 

  28. Okamoto A, Jiang W, Kim SJ, Spillare EA, Stoner GD, Weinstein IB, Harris CC. Overexpression of human cyclin D1 reduces the transforming growth factor β (TGF β) type II receptor and growth inhibition by TGF-β1 in an immortalized human esophageal epithelial cell line. Proc Natl Acad Sci 91:11,576–11,580, 1994.

    CAS  Google Scholar 

  29. Tashijan Ah Jr, Yasumura Y, Levine L, Sato GH, Parker ML. Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 82:342–352, 1968.

    Google Scholar 

  30. Lloyd RV, Coleman K, Fields K, Nath V. Analysis of prolactin and growth hormone production in hyperplastic and neoplastic rat pituitary tissue by the hemolytic plaque assay. Cancer Res 47:1086–1092, 1987.

    Google Scholar 

  31. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsui L-H, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM. A syndrome of multiorgan hyperplasia with features of gigantism, tumor genesis and female sterility in p27kip1-deficient mice. Cell 85:733–744, 1996.

    Article  PubMed  CAS  Google Scholar 

  32. Kiyokawa H, Kinerman RD, Manova M, Todorava KD, Soares VC, Hoffman ES, Ono M, Khanam, D, Hayday AC, Frohman LA, Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27kip1. Cell 85:721–732, 1996.

    Article  PubMed  CAS  Google Scholar 

  33. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishidu N, Horii I, Loh DY, Nakayama K-I. Mice lacking p27 kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell 85:707–720, 1996.

    Article  PubMed  CAS  Google Scholar 

  34. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Phiippe M, Roberts JM. Human cyclin E, a new cyclin, that interacts with two members of the CDC2 gene family. Cell 66:1217–1228, 1991.

    Article  PubMed  CAS  Google Scholar 

  35. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid adenomas. Oncogene 6:449–453, 1991.

    PubMed  CAS  Google Scholar 

  36. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 145:86–96, 1994.

    PubMed  CAS  Google Scholar 

  37. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:699–671, 1994.

    Google Scholar 

  38. Motokura I, Keyomarsi K, Kronenberg HM Arnold A. Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J Biol Chem 267:20,412–20,415, 1992.

    CAS  Google Scholar 

  39. Kato J-Y, Sherr CJ. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. PNAS 90:11,513–11,517, 1993.

    CAS  Google Scholar 

  40. Tamura K, Kanaoka Y, Jinno S, Nagata A, Ogiso Y, Shimizu K, Hayakawa T, Nojima H, Okayama H. Cyclin G: a new mammalian cyclin with homology to fission yeast cigl. Oncogene 8:2113–2118, 1993.

    PubMed  CAS  Google Scholar 

  41. Piechaczyk M, Blanchard JM, Marty L, Dani C, Panabienes F, El Sabrouty S, Fort P, Jeanteur P. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissue. Nucleic Acids Res 12:6951–6963, 1984.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine and Pathology, Mayo Clinic, 55905, Rochester, MN

    Xiang Qian MD, PhD, Long Jin MD & Ricardo V. Lloyd MD, PhD

Authors
  1. Xiang Qian MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Long Jin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ricardo V. Lloyd MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ricardo V. Lloyd MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qian, X., Jin, L. & Lloyd, R.V. TGF-β and estrogen regulate P27Kip1 and cyclin D1 in normal and neoplastic rat pituitary cells. Endocr Pathol 8, 241–250 (1997). https://doi.org/10.1007/BF02738792

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02738792

Key Words

Search

Navigation